(Q35918369)

11 August 2017

1 reference

title

Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide (English)

1 reference

systemic lupus erythematosus

11 August 2017

main subject

1 reference

G E Katsifis

1

1 reference

11 August 2017

A G Tzioufas

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

9

1 reference

11 August 2017

page(s)

673-678

1 reference

Immunomodulatory treatment in patients with rheumatic diseases: mechanisms of action

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Use of testosterone to prevent cyclophosphamide-induced azoospermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Cyclophosphamide and reproductive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Recurrent pregnancy loss and autoantibody profile in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Immune response to the RNA protein particles in systemic lupus erythematosus. A distinctive dichotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Ro60 peptides induce antibodies to similar epitopes shared among lupus-related autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

Preserving ovarian function in patients receiving cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU2012OA

10.1191/0961203304LU2012OA

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference